Annual report pursuant to Section 13 and 15(d)

Revenue Disaggregation

v3.22.2
Revenue Disaggregation
 12 Months Ended
Mar. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

NOTE 17 – Revenue Disaggregation

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table presents the Company’s disaggregated revenues by source:

 

               
   

Year Ended

March 31,

  
    2022     2021  
Product            
Human Care   $ 9,010,000     $ 15,317,000  
Animal Care     3,169,000       3,200,000  
Total Product Revenue     12,179,000       18,517,000  
Service/Royalty     449,000       112,000  
Total   $ 12,628,000     $ 18,629,000  

 

 

The following table shows the Company’s revenues by geographic region:

               
    Year Ended March 31,  
    2022     2021  
United States   $ 3,807,000     $ 5,419,000  
Latin America     2,095,000       5,976,000  
Europe and Rest of the World     6,726,000       7,234,000  
Total   $ 12,628,000     $ 18,629,000  

 

The Company’s service revenues in Latin America amounted to $349,000 and $112,000 for the years ended March 31, 2022 and 2021, respectively.